| Schedule of Segment Reporting Information |
Schedule of Segment Reporting Information
Segment
Reporting for the Three Months Ended September 30, 2026
| | |
Treatment | | |
Services | | |
Consolidated
Total | |
| Revenue from external customers | |
$ | 11,601 | | |
$ | 6,347 | | |
$ | 17,948 | |
| Cost of Goods Sold: | |
| | | |
| | | |
| | |
| Payroll and benefits expenses | |
| 5,728 | | |
| 2,720 | | |
| | |
| Material and supplies expenses | |
| 1,969 | | |
| — | | |
| | |
| Disposal expenses | |
| 1,104 | | |
| — | | |
| | |
| Transportation expenses | |
| 260 | | |
| — | | |
| | |
| Subcontract expenses | |
| — | | |
| 1,088 | | |
| | |
| Other
cost of goods sold (1) | |
| 2,765 | | |
| 1,762 | | |
| | |
| Total cost of goods sold | |
| 11,826 | | |
| 5,570 | | |
| | |
| Gross (loss) profit | |
| (225 | ) | |
| 777 | | |
| | |
| SG&A: | |
| | | |
| | | |
| | |
| Payroll and benefits | |
| 916 | | |
| 399 | | |
| | |
| Other
SG&A (2) | |
| 416 | | |
| 179 | | |
| | |
| Total SG&A | |
| 1,332 | | |
| 578 | | |
| | |
| R&D | |
| 165 | | |
| 3 | | |
| | |
| Gain on disposal of property
and equipment | |
| — | | |
| (5 | ) | |
| | |
| (Loss) income from
operations | |
$ | (1,722 | ) | |
$ | 201 | | |
| (1,521 | ) |
| Interest income | |
| | | |
| | | |
| 240 | |
| Interest expense | |
| | | |
| | | |
| (80 | ) |
| Interest expense-financing fees | |
| | | |
| | | |
| (16 | ) |
| Other income | |
| | | |
| | | |
| 114 | |
| Unallocated
corporate expenses (3) | |
| | | |
| | | |
| (2,145 | ) |
| Loss from continuing
operations before taxes | |
| | | |
| | | |
$ | (3,408 | ) |
Segment
Reporting for the Three Months Ended September 30, 2025
| | |
Treatment | | |
Services | | |
Consolidated
Total | |
| Revenue from external customers | |
$ | 13,114 | | |
$ | 4,340 | | |
$ | 17,454 | |
| Cost of Goods Sold: | |
| | | |
| | | |
| | |
| Payroll and benefits expenses | |
| 4,809 | | |
| 2,358 | | |
| | |
| Material and supplies expenses | |
| 2,158 | | |
| — | | |
| | |
| Disposal expenses | |
| 1,075 | | |
| — | | |
| | |
| Transportation expenses | |
| 361 | | |
| — | | |
| | |
| Subcontract expenses | |
| — | | |
| 118 | | |
| | |
| Other
cost of goods sold (1) | |
| 2,445 | | |
| 1,573 | | |
| | |
| Total cost of goods sold | |
| 10,848 | | |
| 4,049 | | |
| | |
| Gross profit | |
| 2,266 | | |
| 291 | | |
| | |
| SG&A: | |
| | | |
| | | |
| | |
| Payroll and benefits | |
| 947 | | |
| 547 | | |
| | |
| Other
SG&A (2) | |
| 386 | | |
| 199 | | |
| | |
| Total SG&A | |
| 1,333 | | |
| 746 | | |
| | |
| R&D | |
| 257 | | |
| 2 | | |
| | |
| Loss on disposal of property
and equipment | |
| 4 | | |
| — | | |
| | |
| Income (loss) from operations | |
$ | 672 | | |
$ | (457 | ) | |
| 215 | |
| Interest income | |
| | | |
| | | |
| 266 | |
| Interest expense | |
| | | |
| | | |
| (116 | ) |
| Interest expense-financing fees | |
| | | |
| | | |
| (22 | ) |
| Other expense | |
| | | |
| | | |
| (18 | ) |
| Unallocated
corporate expenses (3) | |
| | | |
| | | |
| (2,087 | ) |
Segment
Reporting for the Nine Months Ended September 30, 2026
| | |
Treatment | | |
Services | | |
Consolidated
Total | |
| Revenue from external customers | |
$ | 27,768 | | |
$ | 14,191 | | |
$ | 41,959 | |
| Cost of Goods Sold: | |
| | | |
| | | |
| | |
| Payroll and benefits expenses | |
| 15,950 | | |
| 7,142 | | |
| | |
| Material and supplies expenses | |
| 4,887 | | |
| — | | |
| | |
| Disposal expenses | |
| 3,470 | | |
| — | | |
| | |
| Transportation expenses | |
| 1,085 | | |
| — | | |
| | |
| Subcontract expenses | |
| — | | |
| 1,759 | | |
| | |
| Other
cost of goods sold (1) | |
| 8,087 | | |
| 4,412 | | |
| | |
| Total cost of goods sold | |
| 33,479 | | |
| 13,313 | | |
| | |
| Gross profit | |
| (5,711 | ) | |
| 878 | | |
| | |
| SG&A: | |
| | | |
| | | |
| | |
| Payroll and benefits | |
| 2,685 | | |
| 1,561 | | |
| | |
| Other
SG&A (2) | |
| 1,371 | | |
| 242 | | |
| | |
| Total SG&A | |
| 4,056 | | |
| 1,803 | | |
| | |
| R&D | |
| 584 | | |
| 7 | | |
| | |
| Gain on disposal of property
and equipment | |
| — | | |
| (5 | ) | |
| | |
| Loss from operations | |
$ | (10,351 | ) | |
$ | (927 | ) | |
| (11,278 | ) |
| Interest income | |
| | | |
| | | |
| 624 | |
| Interest expense | |
| | | |
| | | |
| (213 | ) |
| Interest expense-financing fees | |
| | | |
| | | |
| (59 | ) |
| Other income | |
| | | |
| | | |
| 258 | |
| Unallocated
corporate expenses (3) | |
| | | |
| | | |
| (6,378 | ) |
Segment
Reporting for the Nine Months Ended September 30, 2025
| | |
Treatment | | |
Services | | |
Consolidated
Total | |
| Revenue from external customers | |
$ | 33,696 | | |
$ | 12,263 | | |
$ | 45,959 | |
| Cost of Goods Sold: | |
| | | |
| | | |
| | |
| Payroll and benefits expenses | |
| 13,988 | | |
| 6,245 | | |
| | |
| Material and supplies expenses | |
| 4,744 | | |
| — | | |
| | |
| Disposal expenses | |
| 2,391 | | |
| — | | |
| | |
| Transportation expenses | |
| 1,222 | | |
| — | | |
| | |
| Subcontract expenses | |
| — | | |
| 1,184 | | |
| | |
| Other
cost of goods sold (1) | |
| 7,269 | | |
| 4,155 | | |
| | |
| Total cost of goods sold | |
| 29,614 | | |
| 11,584 | | |
| | |
| Gross profit | |
| 4,082 | | |
| 679 | | |
| | |
| SG&A: | |
| | | |
| | | |
| | |
| Payroll and benefits | |
| 2,763 | | |
| 1,732 | | |
| | |
| Other
SG&A (2) | |
| 1,276 | | |
| 573 | | |
| | |
| Total SG&A | |
| 4,039 | | |
| 2,305 | | |
| | |
| R&D | |
| 780 | | |
| 29 | | |
| | |
| Loss (gain) on disposal
of property and equipment | |
| 3 | | |
| (5 | ) | |
| | |
| Loss from operations | |
$ | (740 | ) | |
$ | (1,650 | ) | |
| (2,390 | ) |
| Interest income | |
| | | |
| | | |
| 901 | |
| Interest expense | |
| | | |
| | | |
| (351 | ) |
| Interest expense-financing fees | |
| | | |
| | | |
| (63 | ) |
| Other income | |
| | | |
| | | |
| 171 | |
| Unallocated
corporate expenses (3) | |
| | | |
| | | |
| (6,112 | ) |
| (1) |
Other cost of goods sold for each reportable segment includes:
Treatment
- lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.
Services
- material and supplies, disposal, transportation, lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside
services and general expenses. |
| |
|
| (2) |
Other SG&A for each reportable segment includes:
Treatment-
depreciation and amortization, travel, outside services, repair and maintenance and general expenses.
Services-
travel, outside services, repair and maintenance and general expenses. |
| |
|
| (3) |
The following table reflects
the unallocated corporate expenses. “Other” unallocated corporate expenses consists of repair and maintenance, depreciation
and amortization, travel, public company, outside services, general and R&D expenses. (in thousands) |
|